Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2004 054 285.7 |
96 | EP file number | EAKZ | 13 17 8249.2 |
97 | EP publication number | EPN | 2671581 |
54 | Designation/title | TI | Zusammensetzungen und Verfahren zur Behandlung von Krebs |
51 | IPC main class | ICM (ICMV) | A61K 31/415 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/44 (2006.01), C07D 233/02 (2006.01), C07D 401/00 (2006.01), A61K 31/5377 (2006.01), A61K 31/4166 (2006.01), A61P 35/00 (2006.01), B82Y 5/00 (2011.01), A61K 47/54 (2017.01), A61K 47/68 (2017.01) |
22 | DE application date | DAT | Mar 29, 2004 |
96 | EP application date | EAT | Mar 29, 2004 |
43 | Date of first publication | OT | Dec 11, 2013 |
| Date of publication of grant | PET | Oct 2, 2019 |
71/73 | Applicant/owner | INH | ImmunoGenesis Inc. (n.d.Ges.d. Staates Delaware), Houston, TX, UY |
72 | Inventor | IN | Matteucci, Mark, Portola Valley, CA 94028, US; Rao, Photon, Forster City, CA 94404, US; Duan, Jian-Xin, South San Francisco, CA 94080, US |
74 | Representative | VTR | Kraus & Lederer PartGmbB, 80539 München, DE |
| Address for service | | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 458845 P Mar 28, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 465281 P Apr 21, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002671581 Searchable text:
EP000002671581 Original document:
EP000002671581B1 Searchable text:
EP000002671581B1 |
43 | Date of first publication | EVT | Dec 11, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Jan 24, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 31, 2024 (Show all update days)(Hide all update days)- Jan 24, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 19, 2024 |
| Issue number | HN | 9 |
| Year | PJ | 2024 |
| Publication date | VT | Feb 29, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Immugenesis, Inc. (n.d.Ges.d. Staates Delaware), Houston, TX, US |
71/73 | Previous applicant/owner | INHF | Molecular Templates, Inc., Jersey City, NJ, US |
| Date of update of the procedure | REGT | Feb 29, 2024 |
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 31, 2024 |
| Issue number | HN | 10 |
| Year | PJ | 2024 |
| Publication date | VT | Mar 7, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | ImmunoGenesis Inc. (n.d.Ges.d. Staates Delaware), Houston, TX, UY |
71/73 | Previous applicant/owner | INHF | Immugenesis, Inc. (n.d.Ges.d. Staates Delaware), Houston, TX, US |
| Date of update of the procedure | REGT | Feb 29, 2024 |